Sotac Pharmaceuticals

Sotac Pharmaceuticals Dividends Paid

Total Dividends Paid of Sotac Pharmaceuticals (SOTAC.NS) as of Oct 21, 2026.

Dividends Paid

0.00INR

Last updated:

Total Dividends Paid of Sotac Pharmaceuticals is 2025 0.00 INR. Total Dividends Paid of Sotac Pharmaceuticals was 2024 0.00 INR. It decreases by % lower compared to the previous year.

The Sotac Pharmaceuticals Dividends Paid history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividends Paid
Date
Dividends Paid
Jan 1, 2020
0.00 INR
Jan 1, 2021
0.00 INR
Jan 1, 2022
0.00 INR
Jan 1, 2023
0.00 INR
Jan 1, 2024
0.00 INR
Jan 1, 2025
0.00 INR
The Sotac Pharmaceuticals Dividends Paid history
YEARDividends PaidYoY
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals Ltd develops and manufactures pharmaceutical products under loan license or contract manufacturing agreements for various marketers. The company specializes in Non Beta-Lactam tablets, capsules, syrup, and external preparations, with a therapeutic portfolio covering Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, Anti-Allergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, Anti-Pyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams and Non-IP-Lactams, Anti-Fungal, and Cephalosporin products. Its subsidiaries SOTAC Healthcare, SOTAC Research, and SOTAC Lifescience support its manufacturing and development activities. The company generates revenue by producing pharmaceutical products on a contract manufacturing basis for different marketers, who then market and sell these products under their own brands. Sotac Pharmaceuticals' manufacturing services are utilized by various marketers seeking to outsource production without maintaining their own facilities. The firm's focus on a diverse therapeutic portfolio ensures consistent demand across multiple healthcare segments. Sotac Pharmaceuticals' manufacturing capabilities are tailored to meet the specific requirements of its marketer clients, offering both Non Beta-Lactam and Beta-Lactam product lines. The company's subsidiaries provide additional support in healthcare, research, and lifescience sectors, enhancing its overall service offerings. Its product range spans from basic medications like Anti-Cold and Anti-Allergic to specialized treatments such as Anti-Fungal and Cephalosporin antibiotics. Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotac Pharmaceuticals stock

On Eulerpool you can find the complete historical development of Total Dividends Paid Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Total dividends paid represents the cash distributed to shareholders during the period. It reflects the company's commitment to returning value to shareholders.

Total Dividends Paid's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Dividends Paid's Sotac Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Sotac Pharmaceuticals

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Sotac Pharmaceuticals